David D. Davidar - 08 May 2024 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
Director
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Issuer symbol
GMED
Transactions as of
08 May 2024
Net transactions value
-$1,300,000
Form type
4
Filing time
10 May 2024, 16:48:50 UTC
Previous filing
30 Jan 2024
Next filing
17 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Sale $1,300,000 -20,000 -3.4% $65.00 566,275 08 May 2024 Direct F1
holding GMED Class A Common Stock 205,967 08 May 2024 By Davidar Family Irrevocable Trust U/A 8/6/09 F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 14, 2023 executed by the reporting person.
F2 These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.